A Multidisciplinary Patient Navigation Program Improves Compliance With Adjuvant Breast Cancer Therapy in a Public Hospital

American Journal of Medical Quality

Volumn 32, Issue 4, 2017, Pages 406-413

  Castaldi, Maria ^a   Safadjou, Saman ^b   Elrafei, Tarek ^a   McNelis, John ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b LINCOLN MEDICAL AND MENTAL HEALTH CENTER   (United States)

Author keywords

adjuvant therapy; breast cancer; disparity in health care; patient navigation; public hospital

Indexed keywords

ANTINEOPLASTIC AGENT; HORMONE ANTAGONIST;

ADULT; AFRICAN AMERICAN; AGED; BREAST TUMOR; CANCER STAGING; ETHNOLOGY; FEMALE; HISPANIC; HUMAN; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEW YORK; ORGANIZATION AND MANAGEMENT; PARTIAL MASTECTOMY; PATHOLOGY; PATIENT CARE; PATIENT COMPLIANCE; PROCEDURES; PUBLIC HOSPITAL; SAFETY NET HOSPITAL; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HISPANIC AMERICANS; HORMONE ANTAGONISTS; HOSPITALS, PUBLIC; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM STAGING; NEW YORK CITY; PATIENT COMPLIANCE; PATIENT NAVIGATION; SAFETY-NET PROVIDERS;

EID: 85021728082     PISSN: 10628606     EISSN: 1555824X     Source Type: Journal    
DOI: 10.1177/1062860616656250     Document Type: Article

References (29)

1. Weir HK, Thun MJ, Hankey BF. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst. 2003;95:1276-1299.
2. Li CI, Malone KE, Daling JR., Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003;163:49-56.
3. Griggs JJ, Sorbero ME, Stark AT, Heininger SE, Dick AW., Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat. 2003;81(1):21-31.
4. Shavers VL, Brown ML., Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94:334-357.
5. Mandelblatt JS, Kerner JF, Hadley J. Variations in breast carcinoma treatment in older Medicare beneficiaries: is it black or white. Cancer. 2002;95:1401-1414.
6. Joslyn SA., Racial differences in treatment and survival from early-stage breast carcinoma. Cancer. 2002;95:1759-1766.
7. Moormeier J., Breast cancer in black women. Ann Intern Med. 1996;124:897-905.
8. Bickell NA, Wang JJ, Oluwole S. Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol. 2006;24:1357-1362.
9. Bickell NA, LePar F, Wang JJ, Levental H., Lost opportunities: physicians’ reasons and disparities in breast cancer treatment. J Clin Oncol. 2007;25:2516-2521.
10. Vona-Davis L, Rose DP., The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J Womens Health (Larchmt). 2009;18:883-893.
11. Yood MU, Johnson CC, Blount A. Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst. 1999;91:1487-1491.
12. Bradley CJ, Given CW, Roberts C., Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94:490-496.
13. Bickell NA, Shastri K, Fei K. A tracking and feedback registry to reduce racial disparities in breast cancer care. J Natl Cancer Inst. 2008;100:1717-1723.
14. National Quality Forum. Measure search. http://www.qualityforum.org/QPS. Accessed November 25, 2014.
15. Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet. 2005;365:1687-1717.
16. Veronesi U, Cascinelli N, Mariani L. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227-1232.
17. Fisher B, Anderson S, Bryant J. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241.
18. Wagner EH, Ludman EJ, Aiello Bowles EJ. Nurse navigators in early cancer care: a randomized, controlled trial. J Clin Oncol. 2014;32:12-19.
19. Wells KJ, Battaglia TA, Dudley DJ. Patient navigation: state of the art, or is it science? Cancer. 2008;113:1999-2010.
20. Office of Management and Budget. Revisions to the Standards for the Classification of Federal Data on Race and Ethnicity. https://www.whitehouse.gov/omb/fedreg_1997standards. Published October 30, 1997. Accessed March 11, 2015.
21. Freeman HP, Wasfie TJ., Cancer of the breast in poor black women. Cancer. 1989;63:2562-2569.
22. Freeman HP., Patient navigation: a community centered approach to reducing cancer mortality. J Cancer Educ. 2006;21(1 suppl):S11-S14.
23. Ell K, Padgett D, Vourlekis B. Abnormal mammogram follow-up: a pilot study: women with low income. Cancer Pract. 2002;10:130-138.
24. Gabram SG, Lund MJ, Gardner J. Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population. Cancer. 2008;113:602-607.
25. Dohan D, Schrag D., Using navigators to improve care of underserved patients. Cancer. 2005;104:848-855.
26. Vargas RB, Ryan GW, Jackson CA, Rodriguez R, Freeman HP., Characteristics of the original patient navigation programs to reduce disparities in the diagnosis and treatment of breast cancer. Cancer. 2008;113:426-433.
27. Weber JJ, Mascarenhas DC, Bellin LS, Raab RE, Wong JH., Patient navigation and the quality of breast cancer care: an analysis of the breast cancer care quality indicators. Ann Surg Oncol. 2012;19:3251-3256.
28. Freund KM, Battaglia TA, Calhoun E. Impact of patient navigation on timely cancer care: the patient navigation research program. J Natl Cancer Inst. 2014;106(6):dju115. doi:10.1093/jnci/dju115.
29. Ko NY, Darnell JS, Calhoun E. Can patient navigation improve receipt of recommended breast cancer care? Evidence from the national patient navigation research program. J Clin Oncol. 2014;32:2758-2764.